SIGNIFICANT CUSTOMERS	3 Months Ended
SIGNIFICANT CUSTOMERS	May 31, 2014
SIGNIFICANT CUSTOMERS [Abstract]
SIGNIFICANT CUSTOMERS	NOTE 11 – SIGNIFICANT CUSTOMERS Concentration Risk In the three months ended May 31, 2014, we sold AuraGen related products to two significant customers whose sales comprised 29% and 15% of net sales, respectively. Net accounts receivable from these customers at May 31, 2014 were $21,154 and $6,644 respectively. These customers are not related to or affiliated with us. In the three months ended May 31, 2013, we sold AuraGen related products to four significant customers whose sales comprised 32%, 16%, 15% and 13% of net sales, respectively. Net accounts receivable from these customers at May 31, 2013 were $165,280, $0, $90,279, and $47,163 respectively. These customers are not related to or affiliated with us.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details